drugset / Trial / NCT04456504
HepB-CpG Series for Healthcare Workers Who Are Hepatitis B Vaccine Nonresponders
NaSingle-groupOpen-labelPrevention
Summary
This study is being done to determine if healthcare workers who have previously failed to respond to hepatitis B vaccine series will respond to a hepatitis B with CpG adjuvant (hepB-CpG) (Heplisav-B)
Timeline
- Start
- 2020-09-15
- Primary completion
- 2023-12-06
- Completion
- 2023-12-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEPLISAV-B | Vaccine | — | — |
Indications
No indication recorded.